AlphaMeld
EXAMPLEillustrative portfolio view
AssetPhaseTPP fitLatest readout
Asset A · GLP-1RAPh2b0.9119% Δ wt @ wk 36
Asset B · TYK2 inh.Ph20.78PASI-75: 64%
Asset C · GBA1 chap.Ph1b0.84SAFETY: clean
Asset D · KRAS G12DPh10.66DLT @ 80mg
Asset E · TREM2 ag.Pre-IND0.72tox: 7d ongoing
Per-engagement portfolios — figures illustrativelast sync: 2m ago
PORTFOLIO INTELLIGENCE

AlphaCompass

Define TPPs → monitor outcomes → benchmark competitors → optimize portfolio. Continuously.

  • Per-asset Target Product Profiles
  • Continuous trial-readout monitoring
  • Auto-compare TPP vs. actual outcomes
  • Side-by-side competitor benchmarking
  • Portfolio roll-ups & gap analyses
Get started

Ready to compress your discovery timelines?

See AlphaMeld run a live target-discovery workflow on your therapy area in 30 minutes.